Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Health Catalyst, Inc.HCAT · Entity 1565 | Chief Technology Officer | September 01, 2022 | September 06, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Health Catalyst, Inc.
Report date September 01, 2022 · Filed September 06, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,403 |
Reported balance
After 2022-09-01 transaction · row 1
1 source rowRow 1 · 2022-09-01 · Tax withholding · Disposed 1,413 · Balance 26,403 F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2022 Filed Sep 6, 2022 16:11 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 1,413 | $11.61 | $16,397.87 |
DisclosureSEC source: 0001562180-22-006493 · primarydocument.xml · nonDerivative · entry 1 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,403 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 17:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 49 | $14.95 | $732.66 |
DisclosureSEC source: 0001562180-22-004816 · primarydocument.xml · nonDerivative · entry 2 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,816 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: Represents the weighted average sale price of the shares sold ranging from $14.91 to $15.07 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 17:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 1,364 | $14.24 | $19,419.40 |
DisclosureSEC source: 0001562180-22-004816 · primarydocument.xml · nonDerivative · entry 1 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,865 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: Represents the weighted average sale price of the shares sold ranging from $13.91 to $14.90 per share, inclusive. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 19:36 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 281 | $26.69 | $7,500.26 |
DisclosureSEC source: 0001562180-22-002343 · primarydocument.xml · nonDerivative · entry 3 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,229 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: Represents the weighted average sale price of the shares sold ranging from $25.29 to $27.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (4). Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 19:36 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 1,861 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002343 · primarydocument.xml · nonDerivative · entry 2 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,510 F3 · shares: Represents an award of 1,861 performance-based restricted units ("PRSUs") pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2021, the PRSUs noted above vested on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 19:36 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 1,726 | $26.63 | $45,964.59 |
DisclosureSEC source: 0001562180-22-002343 · primarydocument.xml · nonDerivative · entry 1 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,649 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: Represents the weighted average sale price of the shares sold ranging from $26.23 to $27.44 per share, inclusive. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:23 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002020 · primarydocument.xml · nonDerivative · entry 1 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,375 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2022 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 19:28 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 106 | $0.00 Strike: $10.78 | $0.00 |
DisclosureSEC source: 0001562180-22-000296 · primarydocument.xml · derivative · entry 3 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423 Underlying: Common Stock · 106 shares Expires 2028-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 5,082 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on May 3, 2022. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 19:28 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 106 | $39.76 | $4,214.56 |
DisclosureSEC source: 0001562180-22-000296 · primarydocument.xml · nonDerivative · entry 2 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 19:28 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 106 | $10.78 | $1,142.68 |
DisclosureSEC source: 0001562180-22-000296 · primarydocument.xml · nonDerivative · entry 1 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 17:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 260 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-007902 · primarydocument.xml · derivative · entry 3 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,340 Underlying: Common Stock · 260 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 12,500 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 17:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 260 | $39.56 | $10,285.60 |
DisclosureSEC source: 0001562180-21-007902 · primarydocument.xml · nonDerivative · entry 2 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 17:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 260 | $10.80 | $2,808.00 |
DisclosureSEC source: 0001562180-21-007902 · primarydocument.xml · nonDerivative · entry 1 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 16:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 5,057 | $38.64 | $195,396.41 |
DisclosureSEC source: 0001562180-21-007532 · primarydocument.xml · nonDerivative · entry 5 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 F3 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1. F5 · price: Represents the weighted average sale price of the shares sold ranging from $38.37 to $39.06 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) and (5). Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 16:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,400 | $37.69 | $52,772.44 |
DisclosureSEC source: 0001562180-21-007532 · primarydocument.xml · nonDerivative · entry 4 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,432 F3 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1. F4 · price: Represents the weighted average sale price of the shares sold ranging from $37.35 to $38.21 per share, inclusive. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 16:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 105 | $10.78 Strike: $10.78 | $1,131.90 |
DisclosureSEC source: 0001562180-21-007532 · primarydocument.xml · derivative · entry 6 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 529 Underlying: Common Stock · 105 shares Expires 2028-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 25% of the 5,082 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on May 3, 2022. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 16:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 105 | $42.87 | $4,501.35 |
DisclosureSEC source: 0001562180-21-007532 · primarydocument.xml · nonDerivative · entry 3 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,832 F3 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 16:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 105 | $10.78 | $1,131.90 |
DisclosureSEC source: 0001562180-21-007532 · primarydocument.xml · nonDerivative · entry 2 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2021 Filed Dec 7, 2021 16:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 2,918 | $41.95 | $122,402.81 |
DisclosureSEC source: 0001562180-21-007532 · primarydocument.xml · nonDerivative · entry 1 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,832 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: Represents a weighted average price reported by the broker. These shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 16:12 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 260 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-007342 · primarydocument.xml · derivative · entry 3 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Underlying: Common Stock · 260 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 12,500 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 16:12 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 260 | $44.10 | $11,466.00 |
DisclosureSEC source: 0001562180-21-007342 · primarydocument.xml · nonDerivative · entry 2 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 16:12 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 260 | $10.80 | $2,808.00 |
DisclosureSEC source: 0001562180-21-007342 · primarydocument.xml · nonDerivative · entry 1 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2021 Filed Nov 8, 2021 17:30 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 106 | $0.00 Strike: $10.78 | $0.00 |
DisclosureSEC source: 0001562180-21-006888 · primarydocument.xml · derivative · entry 3 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634 Underlying: Common Stock · 106 shares Expires 2028-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 5,082 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on May 3, 2022. Read SEC document |
| November 03, 2021 Filed Nov 8, 2021 17:30 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 106 | $52.62 | $5,577.72 |
DisclosureSEC source: 0001562180-21-006888 · primarydocument.xml · nonDerivative · entry 2 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1. Read SEC document |
| November 03, 2021 Filed Nov 8, 2021 17:30 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 106 | $10.78 | $1,142.68 |
DisclosureSEC source: 0001562180-21-006888 · primarydocument.xml · nonDerivative · entry 1 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2021 Filed Oct 27, 2021 17:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 260 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-006656 · primarydocument.xml · derivative · entry 3 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,860 Underlying: Common Stock · 260 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 12,500 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| October 25, 2021 Filed Oct 27, 2021 17:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 260 | $50.66 | $13,171.60 |
DisclosureSEC source: 0001562180-21-006656 · primarydocument.xml · nonDerivative · entry 2 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1. Read SEC document |
| October 25, 2021 Filed Oct 27, 2021 17:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 260 | $10.80 | $2,808.00 |
DisclosureSEC source: 0001562180-21-006656 · primarydocument.xml · nonDerivative · entry 1 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 20:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 106 | $0.00 Strike: $10.78 | $0.00 |
DisclosureSEC source: 0001562180-21-006326 · primarydocument.xml · derivative · entry 3 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 740 Underlying: Common Stock · 106 shares Expires 2028-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 5,082 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on May 3, 2022. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 20:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 106 | $49.00 | $5,194.00 |
DisclosureSEC source: 0001562180-21-006326 · primarydocument.xml · nonDerivative · entry 2 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 20:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 106 | $10.78 | $1,142.68 |
DisclosureSEC source: 0001562180-21-006326 · primarydocument.xml · nonDerivative · entry 1 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 17:16 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 260 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-006151 · primarydocument.xml · derivative · entry 3 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,120 Underlying: Common Stock · 260 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 12,500 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 17:16 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 260 | $53.41 | $13,886.60 |
DisclosureSEC source: 0001562180-21-006151 · primarydocument.xml · nonDerivative · entry 2 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 17:16 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 260 | $10.80 | $2,808.00 |
DisclosureSEC source: 0001562180-21-006151 · primarydocument.xml · nonDerivative · entry 1 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 16:08 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,176 | $54.90 | $119,470.89 |
DisclosureSEC source: 0001562180-21-005873 · primarydocument.xml · nonDerivative · entry 3 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 F2 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $54.78 to $55.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth within this Footnote. Read SEC document |
| September 03, 2021 Filed Sep 8, 2021 16:08 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 106 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-005873 · primarydocument.xml · derivative · entry 4 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 846 Underlying: Common Stock · 106 shares Expires 2028-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 5,082 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on May 3, 2022. Read SEC document |
| September 03, 2021 Filed Sep 8, 2021 16:08 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 106 | $54.23 | $5,748.38 |
DisclosureSEC source: 0001562180-21-005873 · primarydocument.xml · nonDerivative · entry 2 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,926 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1. Read SEC document |
| September 03, 2021 Filed Sep 8, 2021 16:08 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 106 | $10.80 | $1,144.80 |
DisclosureSEC source: 0001562180-21-005873 · primarydocument.xml · nonDerivative · entry 1 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 16:06 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 949 | $54.23 | $51,466.26 |
DisclosureSEC source: 0001562180-21-005799 · primarydocument.xml · nonDerivative · entry 1 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,926 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.91 to $54.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 17:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 260 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-005573 · primarydocument.xml · derivative · entry 3 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,380 Underlying: Common Stock · 260 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 12,500 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 17:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 260 | $53.13 | $13,813.80 |
DisclosureSEC source: 0001562180-21-005573 · primarydocument.xml · nonDerivative · entry 2 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,875 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 17:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 260 | $10.80 | $2,808.00 |
DisclosureSEC source: 0001562180-21-005573 · primarydocument.xml · nonDerivative · entry 1 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,135 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 17:17 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 528 | $0.00 Strike: $10.78 | $0.00 |
DisclosureSEC source: 0001562180-21-005302 · primarydocument.xml · derivative · entry 8 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 952 Underlying: Common Stock · 528 shares Expires 2028-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 25% of the 5,082 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on May 3, 2022. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 17:17 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,300 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-005302 · primarydocument.xml · derivative · entry 7 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,640 Underlying: Common Stock · 1,300 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 25% of the 12,500 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 17:17 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 725 | $55.51 | $40,245.77 |
DisclosureSEC source: 0001562180-21-005302 · primarydocument.xml · nonDerivative · entry 6 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,875 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1. F5 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $55.51 to $55.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) through (5). Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 17:17 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,327 | $54.65 | $72,519.62 |
DisclosureSEC source: 0001562180-21-005302 · primarydocument.xml · nonDerivative · entry 5 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,600 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1. F4 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $54.48 to $54.82, inclusive. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 17:17 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,310 | $54.02 | $70,770.52 |
DisclosureSEC source: 0001562180-21-005302 · primarydocument.xml · nonDerivative · entry 4 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,927 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.47 to $54.38, inclusive. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 17:17 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 658 | $52.91 | $34,813.27 |
DisclosureSEC source: 0001562180-21-005302 · primarydocument.xml · nonDerivative · entry 3 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,237 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $52.28 to $53.13, inclusive. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 17:17 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,300 | $10.80 | $14,040.00 |
DisclosureSEC source: 0001562180-21-005302 · primarydocument.xml · nonDerivative · entry 2 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 17:17 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 528 | $10.78 | $5,691.84 |
DisclosureSEC source: 0001562180-21-005302 · primarydocument.xml · nonDerivative · entry 1 Hinton Bryan Richard · CIK 0001855244 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.